Close Menu

NEW YORK (GenomeWeb) — Lucence Diagnostics has partnered with Singapore Diagnostics to distribute its line of blood-based cancer diagnosis and screening tests in the Philippines, the companies announced today.

Lucence's tests are based on its patented sequencing technology and are designed to detect DNA fragments shed by a tumor into the blood.The tests target the most common cancers in Asia such as breast, colon, lung and nasopharyngeal cancer.

Additional terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.